Abstract
Kanamycin, BB-K8, and gentamicin were tested in parallel against 1,037 bacterial strains isolated from clinical material. The activity of BB-K8 at 20 μg/ml was comparable to that of gentamicin at 8 μg/ml against Pseudomonas aeruginosa and against Enterobacteriaceae, with the exception of gentamicin-resistant strains of Proteus rettgeri and Providencia stuartii, in which case the activities of BB-K8 and kanamycin were the same. BB-K8 exhibited little or no activity against streptococci. The activity of BB-K8 was affected by pH and inoculum size. A regression graph for inhibition data with a 10-μg disk of BB-K8 was developed, and synergistic activity of penicillin and BB-K8 against Streptococcus faecalis was tested.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Garrod L. P., Waterworth P. M. Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin. J Clin Pathol. 1969 Sep;22(5):534–538. doi: 10.1136/jcp.22.5.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kawaguchi H., Naito T., Nakagawa S., Fujisawa K. I. BB-K 8, a new semisynthetic aminoglycoside antibiotic. J Antibiot (Tokyo) 1972 Dec;25(12):695–708. doi: 10.7164/antibiotics.25.695. [DOI] [PubMed] [Google Scholar]
- NEWTON B. A. Reversal of the antibacterial activity of polymyxin by divalent cations. Nature. 1953 Jul 25;172(4369):160–161. [PubMed] [Google Scholar]
- Price K. E., Chisholm D. R., Misiek M., Leitner F., Tsai Y. H. Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside. J Antibiot (Tokyo) 1972 Dec;25(12):709–731. doi: 10.7164/antibiotics.25.709. [DOI] [PubMed] [Google Scholar]
- Reiffenstein J. C., Holmes S. W., Hottendorf G. H., Bierwagen M. E. Ototoxicity studies with BB-K8, a new semisynthetic aminoglycoside antibiotic. J Antibiot (Tokyo) 1973 Feb;26(2):94–100. doi: 10.7164/antibiotics.26.94. [DOI] [PubMed] [Google Scholar]
- Top F. H., Jr, Grossman R. A., Bartelloni P. J., Segal H. E., Dudding B. A., Russell P. K., Buescher E. L. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis. 1971 Aug;124(2):148–154. doi: 10.1093/infdis/124.2.148. [DOI] [PubMed] [Google Scholar]
- Traub W. H., Craddock M. E., Raymond E. A., Fox M., McCall C. E. Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection. Appl Microbiol. 1971 Sep;22(3):278–283. doi: 10.1128/am.22.3.278-283.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WEINBERG E. D. The mutual effects of antimicrobial compounds and metallic cations. Bacteriol Rev. 1957 Mar;21(1):46–68. doi: 10.1128/br.21.1.46-68.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Washington J. A., 2nd, Hermans P. E., Martin W. J. In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration. Mayo Clin Proc. 1970 Jul;45(7):527–535. [PubMed] [Google Scholar]
- Washington J. A., 2nd, Ritts R. E., Jr, Martin W. J. In vitro susceptibility of gram-negative bacilli to gentamicin. Mayo Clin Proc. 1970 Feb;45(2):146–149. [PubMed] [Google Scholar]
- Wilkowske C. J., Facklam R. R., Washington J. A., 2nd, Geraci J. E. Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) 1970;10:195–200. [PubMed] [Google Scholar]